Dysport in the Treatment of Glabellar Lines in Chinese Subjects
NCT02450526
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
520
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
BIOLOGICAL:
Botulinum toxin type A
BIOLOGICAL:
Botulinum toxin type A
DRUG:
Placebo
DRUG:
Placebo
Sponsor
Ipsen